Literature DB >> 16213356

Characterization of genomic instability in ulcerative colitis neoplasia leads to discovery of putative tumor suppressor regions.

Ru Chen1, Mary P Bronner, David A Crispin, Peter S Rabinovitch, Teresa A Brentnall.   

Abstract

Ulcerative colitis (UC) is an inflammatory disease of the colon that is associated with increased risk of colorectal cancer associated with genomic instability. We have previously demonstrated that genomic instability is present in UC patients with colonic neoplasia, and hypothesized that the chromosomal alterations may be taking place in regions that are susceptible to mutation or that provide a growth advantage to a cell undergoing neoplastic transformation. In this study, we used two polymerase chain reaction (PCR)-based DNA fingerprinting techniques (arbitrarily primed PCR and inter-simple-sequence-repeat PCR) to study the process of genomic instability. The two techniques of DNA fingerprinting cross-validate the instability observed in these studies. We analyzed the molecular basis of 10 commonly altered DNA bands obtained from DNA fingerprints of biopsies from various histologic grades of UC patients with dysplasia or cancer (UC Progressors). We determined that the band changes in the fingerprint truly represent changes in DNA sequence, and that the fingerprinting provides highly reproducible results. Furthermore, our investigation revealed that 40% of alterations involve repetitive sequences. Two frequently deleted sequences in 6q27 and 2q14 were studied further because they were frequently abnormal in the dysplastic and nondysplastic tissue of UC Progressors. The losses from 6q27 and 2q14 were confirmed by loss of heterozygosity and real-time PCR analysis. Both of these regions in chromosomes 6 and 2 are surrounded by highly repetitive and mobile LINE-1 elements, possibly making the region susceptible to mutational change. These regions were affected (lost) in UC Progressors but not in UC patients who were neoplasia free. Loss of heterozygosity at 6q27 has been described in ovarian and other cancers, while the 2q14 region has been implicated in prostate and sporadic colon cancers. Both regions are likely to contain tumor-suppressor genes. In conclusion, the genomic instability in UC Progressors can occur in regions that are susceptible to change and are locations of putative tumor-suppressor genes.

Entities:  

Mesh:

Year:  2005        PMID: 16213356     DOI: 10.1016/j.cancergencyto.2005.04.006

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  9 in total

1.  Pan-colonic field defects are detected by CGH in the colons of UC patients with dysplasia/cancer.

Authors:  Lisa A Lai; Rosa Ana Risques; Mary P Bronner; Peter S Rabinovitch; David Crispin; Ru Chen; Teresa A Brentnall
Journal:  Cancer Lett       Date:  2012-03-02       Impact factor: 8.679

2.  A role for the mitochondrial pyruvate carrier as a repressor of the Warburg effect and colon cancer cell growth.

Authors:  John C Schell; Kristofor A Olson; Lei Jiang; Amy J Hawkins; Jonathan G Van Vranken; Jianxin Xie; Robert A Egnatchik; Espen G Earl; Ralph J DeBerardinis; Jared Rutter
Journal:  Mol Cell       Date:  2014-10-21       Impact factor: 17.970

3.  Genomic biomarkers to improve ulcerative colitis neoplasia surveillance.

Authors:  Mary P Bronner; Jacintha N O'Sullivan; Peter S Rabinovitch; David A Crispin; Lu Chen; Mary J Emond; Cyrus E Rubin; Teresa A Brentnall
Journal:  Am J Pathol       Date:  2008-11-06       Impact factor: 4.307

4.  Array-based comparative genomic hybridization in ulcerative colitis neoplasia: single non-dysplastic biopsies distinguish progressors from non-progressors.

Authors:  Mary P Bronner; Marek Skacel; David A Crispin; Peter D Hoff; Mary J Emond; Lisa A Lai; Raymond R Tubbs; Jacintha N O'Sullivan; Peter S Rabinovitch; Teresa A Brentnall
Journal:  Mod Pathol       Date:  2010-08-27       Impact factor: 7.842

5.  Clonal expansions in ulcerative colitis identify patients with neoplasia.

Authors:  Jesse J Salk; Stephen J Salipante; Rosa Ana Risques; David A Crispin; Lin Li; Mary P Bronner; Teresa A Brentnall; Peter S Rabinovitch; Marshall S Horwitz; Lawrence A Loeb
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-19       Impact factor: 11.205

6.  Aldehyde dehydrogenase-expressing colon stem cells contribute to tumorigenesis in the transition from colitis to cancer.

Authors:  Joseph E Carpentino; Mark J Hynes; Henry D Appelman; Tong Zheng; Dennis A Steindler; Edward W Scott; Emina H Huang
Journal:  Cancer Res       Date:  2009-10-06       Impact factor: 12.701

Review 7.  Colorectal Cancer Blood-Based Biomarkers.

Authors:  Nina Hauptman; Damjan Glavač
Journal:  Gastroenterol Res Pract       Date:  2017-09-25       Impact factor: 2.260

8.  Recurrence and survival rates of inflammatory bowel disease-associated colorectal cancer following postoperative chemotherapy: a comparative study.

Authors:  Mohannad Dugum; Jingmei Lin; Rocio Lopez; Bassam Estfan; Elena Manilich; Luca Stocchi; Bo Shen; Xiuli Liu
Journal:  Gastroenterol Rep (Oxf)       Date:  2016-06-08

Review 9.  Biomarkers for colitis-associated colorectal cancer.

Authors:  Ru Chen; Lisa A Lai; Teresa A Brentnall; Sheng Pan
Journal:  World J Gastroenterol       Date:  2016-09-21       Impact factor: 5.742

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.